Biotricity Inc
NASDAQ:BTCY 12:28:45 AM EDT
| Market Cap (Intraday) | 32.56M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.65 |
| 50-Day MA | $0.58 |
| 200-Day MA | $0.80 |
Biotricity Inc Stock, NASDAQ:BTCY
203 Redwood Shores Parkway, Suite 600, Redwood City, California 94065
United States of America
Phone: +1.650.832.1626
Number of Employees: 44
Description
Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It is also involved in delivering remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm�s FDA-approved Bioflux MCT technology is comprised of monitoring device and software components, which are made available to the market to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.